Question

Difficulty: MediumPharmacologic Interventions

A 6767-year-old woman is evaluated in the intensive care unit for worsening clinical status. She was admitted 44 days ago after undergoing an elective partial colectomy for diverticular disease. Over the last 44 hours, she has become increasingly lethargic. Her temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 76/42 mmHg76/42\text{ mmHg}, heart rate is 132/min132\text{/min}, and respiratory rate is 24/min24\text{/min}. Her urine output has been 15 mL15\text{ mL} over the past 22 hours. Physical examination reveals a rigid, distended abdomen with diffuse rebound tenderness.

The patient has received 3 L3\text{ L} of intravenous lactated Ringer solution over the past 33 hours, but her blood pressure remains 78/44 mmHg78/44\text{ mmHg}.

Laboratory studies show:
Leukocyte count: 18,500/mm318,500\text{/mm}^3
Lactate: 5.8 mmol/L5.8\text{ mmol/L}
Creatinine: 1.9 mg/dL1.9\text{ mg/dL} (baseline 0.8 mg/dL0.8\text{ mg/dL})
INR: 1.51.5 (normal: 0.8−1.10.8-1.1)

There is no evidence of active bleeding from the surgical site or other orifices. Blood cultures and abdominal imaging have been ordered.

Which of the following pharmacologic interventions are appropriate for this patient at this time? (Select all that apply)

  1. Initiate a continuous intravenous infusion of norepinephrineAnswer
  2. Administer intravenous cefepime and metronidazoleAnswer
  3. C
    Administer intravenous ampicillin-sulbactam as empiric monotherapy
  4. D
    Transfuse fresh frozen plasma
  5. E
    Administer intravenous metoprolol

Answer

The correct interventions are to initiate a continuous intravenous infusion of norepinephrine and to administer intravenous cefepime and metronidazole.
The correct interventions directly address the two most life-threatening issues in this scenario: fluid-refractory hypotension and a severe, healthcare-associated intra-abdominal infection. Following adequate fluid resuscitation, norepinephrine is the guideline-concordant first-line vasopressor to restore mean arterial pressure. Concurrently, an anastomotic leak or generalized peritonitis occurring days after hospital admission requires aggressive empiric antimicrobial therapy targeting resistant Gram-negative bacilli (including Pseudomonas) and anaerobic bacteria. The combination of cefepime (antipseudomonal cephalosporin) and metronidazole (anaerobic coverage) is highly appropriate.

Step-by-Step Solution

1
Analyze the patient's hemodynamic status and response to initial therapy.
The patient remains hypotensive (78/44 mmHg78/44\text{ mmHg}) and poorly perfused (elevated lactate, oliguria) despite adequate fluid resuscitation (30 mL/kg30\text{ mL/kg}), indicating fluid-refractory septic shock.
This confirms the immediate need for vasoactive support rather than continued fluid loading alone.
2
Determine the optimal vasopressor for this clinical state.
Norepinephrine is selected as the first-line vasopressor.
Current critical care guidelines strongly recommend norepinephrine as the initial vasopressor of choice to improve mean arterial pressure in septic shock.
3
Identify the suspected source of infection and the appropriate empiric antimicrobial coverage.
The clinical picture strongly suggests a post-operative intra-abdominal catastrophe (e.g., anastomotic leak). Empiric antibiotics must be broad-spectrum, covering resistant hospital-acquired Gram-negative rods (including Pseudomonas aeruginosa) and anaerobes. Cefepime combined with metronidazole fulfills these criteria.
Delayed or inappropriate antimicrobial therapy significantly increases mortality in septic shock, particularly in healthcare-associated infections where resistant organisms are prevalent.

Key Concept

The initial pharmacologic management of fluid-refractory septic shock secondary to a healthcare-associated intra-abdominal infection requires the immediate initiation of a first-line vasopressor (norepinephrine) and broad-spectrum antimicrobials with antipseudomonal and anaerobic coverage (e.g., cefepime plus metronidazole).
Rate this question